Prognostics elements on multivessel disease and coronary artery disease

Session comprising selected EuroPCR 2026 abstract submissions

Moderator: D. Erlinge

Speakers: K. Yan, N. Kanehama, A. Raval, D. Cazeiro, L. Bao, J. He

Summary

This session examines key prognostic elements in multivessel and coronary artery disease, featuring studies on mechanical circulatory support across LDL-C levels, biomarkers impacting periprocedural myocardial infarction, autologous cell therapy outcomes for refractory angina, and novel risk stratification indices. It also addresses prognosis in cancer patients and the association of inflammatory markers with atherosclerotic burden.

Presentations available when logged in:

Differential prognostic effects of MCSF across LDL-C levels in multivessel coronary artery disease
Impact of post-PCI CK-MB and high-sensitivity troponin on periprocedural myocardial infarction
Autologous mononuclear cell injections for refractory angina: CardiAMP CMI roll-in cohort results
Prognosis of severe coronary disease in cancer patients treated without revascularisation
Association of elevated Lp(a) and hs-CRP with multi-atherosclerotic burden in patients with coronary artery disease

Your free My PCR account will enable you to:

Become a PCR Companion
Access slide presentations from PCR Courses
Watch session videos and LIVE cases
Discuss cases with your peers
Submit and register for PCR Courses
Register for and view PCR Webinars
Read a selection of articles in EuroIntervention
And more…

Prognostics elements on multivessel disease and coronary artery disease

Session comprising selected EuroPCR 2026 abstract submissions

Log in or create account for free